The Hindu·2 min read·medium
Gland Pharma gets U.S. FDA nod for Sugammadex injection
T
The Hindu Bureau
✦AI Summary
Gland Pharma shares rose after receiving U.S. FDA approval for its Sugammadex injection, a drug used for reversing neuromuscular blockade during surgery. The company has already launched the product in the U.S. market.
Shares of Gland Pharma were in the spotlight on Tuesday, rising more than 4%, after the Hyderabad-based generic injectable drugmaker got the U.S. Food and Drug Administration (FDA) approval for its abbreviated new drug application for Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vials.
businesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in